Novel approaches for the treatment of HIV.
Arroyo
H T
HT
D000225:Adenine / Q000009:adverse effects / Q000627:therapeutic use; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D048588:Benzoxazines; D002219:Carbamates; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000009:adverse effects / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005663:Furans; D015316:Genetic Therapy; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D010078:Oxazines / Q000009:adverse effects / Q000627:therapeutic use; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D016335:Zinc Fingers; D000099227:Abacavir
D000225:Adenine; D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D002219:Carbamates; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D005663:Furans; D019428:HIV Integrase Inhibitors; D017320:HIV Protease Inhibitors; D006571:Heterocyclic Compounds; D010078:Oxazines; D019707:Receptors, Chemokine; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir; C098320:efavirenz